The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index; none of the 23 sources its claims cite is checked for support yet.
High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa
Open accessAbstract
It has been reported that ACE2 is the main host cell receptor of 2019-nCoV and plays a crucial role in the entry of virus into the cell to cause the final infection. To investigate the potential route of 2019-nCov infection on the mucosa of oral cavity, bulk RNA-seq profiles from two public databases including The Cancer Genome Atlas (TCGA) and Functional Annotation of The Mammalian Genome Cap Analysis of Gene Expression (FANTOM5 CAGE) dataset were collected. RNA-seq profiling data of 13 organ types with para-carcinoma normal tissues from TCGA and 14 organ types with normal tissues from FANTOM5 CAGE were analyzed in order to explore and validate the expression of ACE2 on the mucosa of oral cavity. Further, single-cell transcriptomes from an independent data generated in-house were used to identify and confirm the ACE2-expressing cell composition and proportion in oral cavity. The results demonstrated that the ACE2 expressed on the mucosa of oral cavity. Interestingly, this receptor was highly enriched in epithelial cells of tongue. Preliminarily, those findings have explained the basic mechanism that the oral cavity is a potentially high risk for 2019-nCoV infectious susceptibility and provided a piece of evidence for the future prevention strategy in dental clinical practice as well as daily life.
Verification finished with gaps
Some checks didn’t finish. The results below cover the steps that did.
- Registry recordVerified
- Full textRead the full text
- Reference list26 references found
- Reference check27 of 27 references checked
- StatisticsRecomputed
- Claims33 claims anchored to a quote
- Cited sourcesChecked
- Self-checkDidn’t finish — the rest of the report still applies.
- VerificationFindings verified
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
14 Not checked yet · 8 Own result · 6 Own method · 5 Own interpretation
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The results demonstrated that the ACE2 expressed on the mucosa of oral cavity.”
- Also stated in: § Public bulk RNA-seq dataset analysis · hedged
“According to the mean expression of ACE2, the mucosa of oral cavity could express ACE2, and the results were validated by the data of normal tissues from the FANTOM5 CAGE dataset (Fig. 1b).”
§ High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa > Abstract
boosted- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption: Public TCGA para-carcinoma normal tissues and FANTOM5 normal tissues are adequate proxies for normal oral mucosa.
- Rests on an assumption: The FANTOM5 CAGE dataset with only two tongue samples can validate ACE2 expression in the oral cavity.
- Also stated in: § Public bulk RNA-seq dataset analysis · hedged
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Fig. 1a showed that ACE2 could be expressed in various organs, the mean expression of different organs could be found in Table 1.”
§ High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa > Results > Public bulk RNA-seq dataset analysis
hedged- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption: Public TCGA para-carcinoma normal tissues and FANTOM5 normal tissues are adequate proxies for normal oral mucosa.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“These findings indicated that oral cavity could be regarded as potentially high risk for 2019-nCov infectious susceptibility.”
- Also stated in: § Abstract · hedged
“Preliminarily, those findings have explained the basic mechanism that the oral cavity is a potentially high risk for 2019-nCoV infectious susceptibility”
§ High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa > Discussion
hedgedcorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption: ACE2 RNA expression levels in tissues indicate the presence of functional ACE2 receptor protein and susceptibility to 2019-nCoV infection.
- Also stated in: § Abstract · hedged
None of the sources cited for this claim have been checked yet.
In the paper
“which from our previous project found no significant expression difference among the common epithelial markers in our past study and other previous study22–24.”
§ High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa > Discussion
What the sources say
- Not checked yetcites [22] Dionne, K. R., Warnakulasuriya, S., Zain, R. B. & Cheong, S. C. Potentially malignant disorders of the oral cavity: current practice and future directions in the clinic and laboratory. Int. J. Cancer 136, 503–515 (2015). source
- Not checked yetcites [23] Li, J. et al. Associations between proteasomal activator PA28γ and outcome of oral squamous cell carcinoma: evidence from cohort studies and functional analyses. EBioMedicine 2, 851–858 (2015). source
- Not checked yetcites [24] Wang, Z. et al. RACK1, an excellent predictor for poor clinical outcome in oral squamous carcinoma, similar to Ki67. Eur. J. Cancer 45, 490–496 (2009). source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“According to the study of Zhao et al.11, the ACE2 expression in lung is concentrated in a small population of type II alveolar cells (AT2), that may cause the relatively low ACE2 expression of lung in bulk-seq RNA datasets analysis.”
§ High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa > Discussion
What the sources say
- Not checked yetcites Zhao et al.11 Zhao, Y. et al. Single-cell RNA expression profiling of ACE2, the putative receptor of Wuhan 2019-nCov. Preprint at https://www.biorxiv.org/content/10.1101/2020.01.26.919985v1 (2020).
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“Previous studies have investigated the ACE2 mRNA and protein expression in various tissues by bulk samples17,18, however, the distribution of ACE2 through bulk data could not indicate the cell type-specific expression of ACE2.”
§ High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa > Discussion
What the sources say
- Not checked yetcites [17] Harmer, D., Gilbert, M., Borman, R. & Clark, K. L. Quantitative mRNA expression profiling of ACE 2, a novel homologue of angiotensin converting enzyme. FEBS Lett. 532, 107–110 (2002). source
- Not checked yetcites [18] Hamming, I. et al. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J. Pathol. 203, 631–637 (2004). source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“These findings indicated that those organs with high ACE2-expressing cells should be considered as potential high risk for 2019-nCoV infection10.”
§ High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa > Introduction
What the sources say
- Not checked yetcites [10] Zou, X. et al. The single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to Wuhan 2019-nCoV infection. Front. Med. http://journal.hep.com.cn/fmd/EN/10.1007/s11684-020-0754-0 (2020). source
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Zhou et al.4 also proved that 2019-nCoV does not use other coronavirus receptors, aminopeptidase N, and dipeptidyl peptidase 4.”
§ High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa > Introduction
What the sources say
- Not checked yetcites Zhou et al.4 Zhou, P. et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. https://doi.org/10.1038/s41586-020-2012-7 (2020). source
boosted- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“The study of Xu et al.9 found that the RBD domain of the 2019-nCoV S-protein supports strong interaction with human ACE2 molecules.”
§ High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa > Introduction
What the sources say
- Not checked yetcites Xu et al.9 Xu, X. et al. Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission. Sci. China Life Sci. https://doi.org/10.1007/s11427-020-1637-5 (2020). source
boostedcorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Thus, our results support that in addition to the respiratory droplets and direct contact, fecal–oral transmission might also be the route of transmission of 2019-nCoV.”
§ High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa > Discussion
What the sources say
- Not checked yetcites [20] Guan, W.-J. et al. Clinical characteristics of 2019 novel coronavirus infection in China. Preprint at https://www.medrxiv.org/content/10.1101/2020.02.06.20020974v1 (2020).
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption: ACE2 RNA expression levels in tissues indicate the presence of functional ACE2 receptor protein and susceptibility to 2019-nCoV infection.
- It may state two separate claims as one. 18
- The quote only partly states this claim. 2
- Probably not a substantial claim. 10
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and higher in oral tongue than buccal and gingival tissues (95.86% ACE2-positive cells located in oral tongue).”
- Also stated in: § Discussion · boosted
“The results of our single cell RNA-seq profiles validated the ACE2 expression in oral cavity, and the level of ACE2 expression in oral tissues was higher in tongue than buccal or gingival tissues.”
§ High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa > Results > Single cell RNA-seq analysis of oral tissues
boostedcorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- Rests on an assumption: The four in-house oral tissue samples are representative of normal oral mucosa and of the oral cavity generally.
- Also stated in: § Discussion · boosted
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and the ACE2 was highly enriched in epithelial cells, of which 93.38% ACE2-positive cells belong to epithelial cells (Fig. 2f).”
§ High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa > Results > Single cell RNA-seq analysis of oral tissues
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one. The quote only partly states this claim.
- Rests on an assumption: The four in-house oral tissue samples are representative of normal oral mucosa and of the oral cavity generally.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Figure 2e shows that the ACE2-positive cells could be found in oral tissues including epithelial cells (1.19% ACE2-positive cells), T cells (<0.5%), B cells (<0.5%), and fibroblast (<0.5%)”
- Also stated in: § Discussion · plain
“Interestingly, we found that the ACE2 also expressed in lymphocytes within oral mucosa, and similar results were found in various organs of the digestive system and in lungs11,12.”
§ High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa > Results > Single cell RNA-seq analysis of oral tissues
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- Rests on an assumption: The four in-house oral tissue samples are representative of normal oral mucosa and of the oral cavity generally.
- Also stated in: § Discussion · plain
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“After the data preprocessing (shown in section “Materials and methods”), 22 969 cells were acquired and 7 cell types were identified (Fig. 2a), including epithelial cells”
§ High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa > Results > Single cell RNA-seq analysis of oral tissues
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one. The quote only partly states this claim.
- Rests on an assumption: The four in-house oral tissue samples are representative of normal oral mucosa and of the oral cavity generally.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“When we combined the base of tongue, floor of mouth and oral cavity as other sites, and compared them with oral tongue, we found the obvious tendency that the mean expression of ACE2 was higher in oral tongue (13 tissues) than others (19 tissues) (Fig. 1d), while may due to the limitation of the sample size, the p value was not significant (P = 0.062).”
§ High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa > Results > Public bulk RNA-seq dataset analysis
hedged- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- Rests on an assumption: The TCGA site annotations for oral cavity samples are accurate.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“According to Fig. 2c, d, we confirmed the ACE2 was expressed in oral tissues (0.52% ACE2-positive cells)”
§ High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa > Results > Single cell RNA-seq analysis of oral tissues
boosted- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- Rests on an assumption: The four in-house oral tissue samples are representative of normal oral mucosa and of the oral cavity generally.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The above results indicated that the ACE2 could be expressed on the epithelial cells of the oral mucosa and highly enriched in tongue epithelial cells.”
- Also stated in: § Abstract · plain
“Interestingly, this receptor was highly enriched in epithelial cells of tongue.”
§ High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa > Results > Single cell RNA-seq analysis of oral tissues
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- Rests on an assumption: The four in-house oral tissue samples are representative of normal oral mucosa and of the oral cavity generally.
- Also stated in: § Abstract · plain
In the paper
“Even though, the result of Zou et al. indicated that the respiratory tract should also be considered as a vulnerable target to 2019-nCoV infection10.”
§ High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa > Discussion
What the sources say
- Not checked yetcites [10] Zou, X. et al. The single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to Wuhan 2019-nCoV infection. Front. Med. http://journal.hep.com.cn/fmd/EN/10.1007/s11684-020-0754-0 (2020). source
hedged- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“These findings suggest that the ACE2 plays an important role in cellular entry, thus ACE2-expressing cells may act as target cells and are susceptible to 2019-nCoV infection10.”
§ High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa > Introduction
What the sources say
- Not checked yetcites [10] Zou, X. et al. The single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to Wuhan 2019-nCoV infection. Front. Med. http://journal.hep.com.cn/fmd/EN/10.1007/s11684-020-0754-0 (2020). source
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The ACE2-expressing cells in oral tissues, especially in epithelial cells of tongue, might provide possible routes of entry for the 2019-nCov, which indicate oral cavity might be a potential risk route of 2019-nCov infection.”
§ High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa > Discussion
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- Rests on an assumption: ACE2 RNA expression levels in tissues indicate the presence of functional ACE2 receptor protein and susceptibility to 2019-nCoV infection.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“The RNA-seq data were batch effects normalized and log2-transformed for the subsequent analysis.”
§ High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa > Materials and methods > Public datasets acquisition and analysis
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. It may state two separate claims as one.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“The “sctransform” wrapper in Seurat was applied to normalize the data and remove confounding sources of variation”
§ High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa > Materials and methods > Single cell RNA-seq data preprocessing and analysis
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Study of Zhou et al.4 indicated that the angiotensin-converting enzyme II (ACE2) is likely the cell receptor of 2019-nCoV, which were also the receptor for SARS-CoV and HCoV-NL637,8.”
§ High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa > Introduction
What the sources say
- Not checked yetcites [7] Li, W. et al. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature 426, 450–454 (2003). source
- Not checked yetcites [8] Hofmann, H. et al. Human coronavirus NL63 employs the severe acute respiratory syndrome coronavirus receptor for cellular entry. Proc. Natl Acad. Sci. USA 102, 7988–7993 (2005). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
None of the sources cited for this claim have been checked yet.
In the paper
“The four were taken from three patients with an average age of 50, which were all diagnosed as hyperkeratosis without dysplasia by pathologists, just showing an increase in cell number in the spinous layer and/or in the basal/parabasal cell layers without cellular atypia, and its genetic profiles would be much more closed to normal tissue than malignant tissue22–24.”
§ High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa > Materials and methods > Oral tissues of in-house cohort
What the sources say
- Not checked yetcites [22] Dionne, K. R., Warnakulasuriya, S., Zain, R. B. & Cheong, S. C. Potentially malignant disorders of the oral cavity: current practice and future directions in the clinic and laboratory. Int. J. Cancer 136, 503–515 (2015). source
- Not checked yetcites [23] Li, J. et al. Associations between proteasomal activator PA28γ and outcome of oral squamous cell carcinoma: evidence from cohort studies and functional analyses. EBioMedicine 2, 851–858 (2015). source
- Not checked yetcites [24] Wang, Z. et al. RACK1, an excellent predictor for poor clinical outcome in oral squamous carcinoma, similar to Ki67. Eur. J. Cancer 45, 490–496 (2009). source
hedgedn = 3- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Recently developed single-cell RNA-sequencing technology enabled the generation of vast amounts of the transcriptomic data at cellular resolution19.”
§ High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa > Discussion
What the sources say
- Not checked yetcites [19] Rostom, R., Svensson, V., Teichmann, S. A. & Kar, G. Computational approaches for interpreting scRNA-seq data. FEBS Lett. 591, 2213–2225 (2017). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim.
In the paper
“Study of Zhou et al.4 indicated that the angiotensin-converting enzyme II (ACE2) is likely the cell receptor of 2019-nCoV, which were also the receptor for SARS-CoV and HCoV-NL637,8.”
§ High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa > Introduction
What the sources say
- Not checked yetcites Zhou et al.4 Zhou, P. et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. https://doi.org/10.1038/s41586-020-2012-7 (2020). source
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“High ACE2 expression was identified in type II alveolar cells (AT2) of lung10–12, esophagus upper and stratified epithelial cells, absorptive enterocytes from ileum and colon12, cholangiocytes13, myocardial cells, kidney proximal tubule cells, and bladder urothelial cells10.”
§ High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa > Introduction
What the sources say
- Not checked yetcites [10] Zou, X. et al. The single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to Wuhan 2019-nCoV infection. Front. Med. http://journal.hep.com.cn/fmd/EN/10.1007/s11684-020-0754-0 (2020). source
- Not checked yetcites [11] Zhao, Y. et al. Single-cell RNA expression profiling of ACE2, the putative receptor of Wuhan 2019-nCov. Preprint at https://www.biorxiv.org/content/10.1101/2020.01.26.919985v1 (2020).
- Not checked yetcites [12] Zhang, H. et al. The digestive system is a potential route of 2019-nCov infection: a bioinformatics analysis based on single-cell transcriptomes. Preprint at https://www.biorxiv.org/content/10.1101/2020.01.30.927806v1 (2020). source
- Not checked yetcites [13] Chai, X. et al. Specific ACE2 expression in cholangiocytes may cause liver damage after 2019-nCoV infection. Preprint at https://www.biorxiv.org/content/10.1101/2020.02.03.931766v1 (2020). source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. It may state two separate claims as one.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“The uniform manifold approximation and projection (UMAP) was used for dimensionality reduction and clustering the cells, cell types were assigned based on their canonical markers.”
§ High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa > Materials and methods > Single cell RNA-seq data preprocessing and analysis
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“Our results are mainly based on public datasets and single cell RNA-sequencing data of in-house oral tissues with minimal diseased lesion”
§ High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa > Discussion
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. It may state two separate claims as one.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“as only two samples of this dataset which owns 60 samples in total located in the tongue, we just downloaded 14 organ types to validate the ACE2 expression in oral cavity with bar plot”
§ High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa > Materials and methods > Public datasets acquisition and analysis
plainn = 2- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The ACE2 expression profile in various organs, tissues, and cell types, provides the bioinformatics evidence for the potential infection routes of 2019-nCov, which might also be associated with presented symptoms.”
§ High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa > Discussion
hedgedcorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- Rests on an assumption: ACE2 RNA expression levels in tissues indicate the presence of functional ACE2 receptor protein and susceptibility to 2019-nCoV infection.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“To control quality, we removed cells with <200 genes and 500 UMI counts, and as well as the cells with mitochondrial content higher than 5%. Besides, the genes detected in <3 cells were filtered out.”
§ High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa > Materials and methods > Single cell RNA-seq data preprocessing and analysis
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
The paper relies on this without support.
ACE2 RNA expression levels in tissues indicate the presence of functional ACE2 receptor protein and susceptibility to 2019-nCoV infection.
“The expression and distribution of the ACE2 in human body may indicate the potential infection routes of 2019-nCoV.”
The paper relies on this without support.
The four in-house oral tissue samples are representative of normal oral mucosa and of the oral cavity generally.
“Single cell RNA-seq was utilized for four oral tissues, and the data was analyzed to confirm the above results and assess the cell type-specific expression of ACE2.”
The paper relies on this without support.
Public TCGA para-carcinoma normal tissues and FANTOM5 normal tissues are adequate proxies for normal oral mucosa.
“Bulk RNA-seq data of para-carcinoma normal tissues which were taken as control tissues in the studies were downloaded from The Cancer Genome Atlas (TCGA; https://www.cancer.gov/tcga), and 695 para-carcinoma normal tissues distributed in different organs were obtained for this study”
The paper relies on this without support.
The FANTOM5 CAGE dataset with only two tongue samples can validate ACE2 expression in the oral cavity.
“as only two samples of this dataset which owns 60 samples in total located in the tongue, we just downloaded 14 organ types to validate the ACE2 expression in oral cavity with bar plot”
The paper relies on this without support.
The TCGA site annotations for oral cavity samples are accurate.
“According to the site information provided by the TCGA, among the 32 adjacent normal tissues, 13 tissues located in the oral tongue, 2 tissues located in the base of tongue, 3 tissues located in the floor of mouse, and 14 tissues did not definite the site and were just put into the category of oral cavity.”
The paper relies on this without support.
2019-nCoV infection hardly presents oral symptoms.
“although 2019-ncov infection hardly presented oral symptoms”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“angiotensinconverting enzyme 2 receptor, which is used by SARS-CoV-2 to bind and penetrate into the cell, is widely expressed on the epithelial cells of the mucosa of the oral cavity [7].”
From Self-reported Olfactory and Taste Disorders in Patients With Severe Acute Respiratory Coronavirus 2 Infection: A Cross-sectional Study (2020) · cites this paper as [7]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
This check didn’t finish.
Citations
Cites
MAFFT Multiple Sequence Alignment Software Version 7: Improvements in Performance and Usability
Katoh, K., & Standley, D. M. (2013) · Molecular Biology and Evolution · doi:10.1093/molbev/mst010 · Cited by 46,209
Clinical characteristics of coronavirus disease 2019 in China
Guan, W.-J., Ni, Z.-Y., Hu, Y., Liang, W.-H., Ou, C.-Q., He, J.-X., Liu, L., Shan, H., Lei, C.-L., Hui, D. S. C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2002032 · Cited by 30,246
A novel coronavirus from patients with pneumonia in China, 2019
Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B., Song, J., Zhao, X., Huang, B., Shi, W., Lu, R., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001017 · Cited by 28,244
A pneumonia outbreak associated with a new coronavirus of probable bat origin
Zhou, P., Yang, X.-L., Wang, X.-G., Hu, B., Zhang, L., Zhang, W., Si, H.-R., Zhu, Y., Li, B., Huang, C.-L., et al. (2020) · Nature · doi:10.1038/s41586-020-2012-7 · Cited by 21,969
Self-citationWang, D., Hu, B., Hu, C., Zhu, F., Liu, X., Zhang, J., Wang, B., Xiang, H., Cheng, Z., Xiong, Y., et al. (2020) · JAMA · doi:10.1001/jama.2020.1585 · Cited by 20,148
La certeza de lo impredecible: Cultura Educación y Sociedad en tiempos de COVID19
Martínez González, M. (2020) · DSPACE System - Metalibrary (University of the Coast) · Cited by 18,463
Lu, R., Zhao, X., Li, J., Niu, P., Yang, B., Wu, H., Wang, W., Song, H., Huang, B., Zhu, N., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30251-8 · Cited by 11,907
A novel coronavirus outbreak of global health concern
Wang, C., Horby, P. W., Hayden, F. G., & Gao, G. F. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30185-9 · Cited by 7,700
Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus
Li, W., Moore, M. J., Vasilieva, N., Sui, J., Wong, S. K., Berne, M. A., Somasundaran, M., Sullivan, J. L., Luzuriaga, K., Greenough, T. C., et al. (2003) · Nature · doi:10.1038/nature02145 · Cited by 5,923
Hamming, I., Timens, W., Bulthuis, M., Lely, A., Navis, G., & van Goor, H. (2004) · The Journal of Pathology · doi:10.1002/path.1570 · Cited by 5,676
Cited by
Sorted by citations
Items 401–500 of 1,002
Riestra‐Ayora, J., Yanes‐Diaz, J., Estéban-Sánchez, J., Vaduva, C., Molina‐Quiros, C., Larrán-Jiménez, A., & Martín-Sanz, E. (2021) · European Archives of Oto-Rhino-Laryngology · doi:10.1007/s00405-021-06764-y · Cited by 59
Niles, M. A., Gogesch, P., Kronhart, S., Iannazzo, S. O., Kochs, G., Waibler, Z., & Anzaghe, M. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.647824 · Cited by 59
Platelet activation by SARS-CoV-2 implicates the release of active tissue factor by infected cells
Puhm, F., Allaeys, I., Lacasse, É., Dubuc, I., Galipeau, Y., Zaid, Y., Khalki, L., Belleannée, C., Durocher, Y., Brisson, A. R., et al. (2022) · Blood Advances · doi:10.1182/bloodadvances.2022007444 · Cited by 58
Underlying Chronic Disease and COVID-19 Infection: A State-of-the-Art Review
Haybar, H., Kazemnia, K., & Rahim, F. (2020) · Jundishapur Journal of Chronic Disease Care · doi:10.5812/jjcdc.103452 · Cited by 58
Yüce, M. Ö., Adalı, E., & Kanmaz, B. (2020) · Irish Journal of Medical Science (1971 -) · doi:10.1007/s11845-020-02312-5 · Cited by 57
Valenzuela, G., Jara, R., Watterson, D., Modhiran, N., Amarilla, A. A., Himelreichs, J., Khromykh, A. A., Salinas-Rebolledo, C., Pinto, T., Cheuquemilla, Y., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-82833-w · Cited by 52
Ghasemzadeh, M., Ghasemzadeh, A., & Hosseini, E. (2021) · Human Immunology · doi:10.1016/j.humimm.2021.09.004 · Cited by 55
Extracellular Vesicle-Based Therapy for COVID-19: Promises, Challenges and Future Prospects
Karn, V., Ahmed, S., Tsai, L.-W., Dubey, R., Ojha, S. K., Singh, H. N., Kumar, M., Gupta, P. K., Sadhu, S., Jha, N. K., et al. (2021) · Biomedicines · doi:10.3390/biomedicines9101373 · Cited by 58
COVID-19 as a trigger of irritable bowel syndrome: A review of potential mechanisms
Settanni, C. R., Ianiro, G., Ponziani, F. R., Bibbò, S., Segal, J. P., Cammarota, G., & Gasbarrini, A. (2021) · World Journal of Gastroenterology · doi:10.3748/wjg.v27.i43.7433 · Cited by 59
Alimoradi, N., Sharqi, M., Firouzabadi, D., Sadeghi, M. M., Moezzi, S. M. I., & Firouzabadi, N. (2022) · Virology Journal · doi:10.1186/s12985-022-01782-6 · Cited by 61
Hematological alterations associated with long COVID-19
Lechuga, G. C., Morel, C. M., & De-Simone, S. G. (2023) · Frontiers in Physiology · doi:10.3389/fphys.2023.1203472 · Cited by 67
Xu, T., Gao, X., Wu, Z., Selinger, D. W., & Zhou, Z. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.04.01.017624 · Cited by 57
Ghafouri‐Fard, S., Noroozi, R., Omrani, M. D., Branicki, W., Pośpiech, E., Sayad, A., Pyrć, K., Łabaj, P. P., Vafaee, R., Taheri, M. N., et al. (2020) · Vascular Pharmacology · doi:10.1016/j.vph.2020.106680 · Cited by 57
Obesity and COVID-19: Oro-Naso-Sensory Perception
Khan, A. S., Hichami, A., & Khan, N. A. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9072158 · Cited by 57
Chowdhury, R., Boorla, V. S., & Maranas, C. D. (2020) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2020.09.019 · Cited by 56
Capocasale, G., Nocini, R., Faccioni, P., Donadello, D., Bertossi, D., Albanese, M., & Zotti, F. (2020) · Clinical and Experimental Dental Research · doi:10.1002/cre2.332 · Cited by 58
Karmouty‐Quintana, H., Thandavarayan, R. A., Keller, S. P., Sahay, S., Pandit, L. M., & Akkanti, B. H. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21218081 · Cited by 60
Husaini, A. M., Jan, K. N., & Wani, G. A. (2021) · Heliyon · doi:10.1016/j.heliyon.2021.e07068 · Cited by 57
Kumar, S., Sarma, P., Kaur, H., Prajapat, M., Bhattacharyya, A., Avti, P., Sehkhar, N., Kaur, H., Bansal, S., Mahendiratta, S., et al. (2021) · Tissue and Cell · doi:10.1016/j.tice.2021.101497 · Cited by 60
The efficacy of bio-aerosol reducing procedures used in dentistry: a systematic review
Samaranayake, L. P., Fakhruddin, K. S., Buranawat, B., & Panduwawala, C. (2020) · Acta Odontologica Scandinavica · doi:10.1080/00016357.2020.1839673 · Cited by 56
A Call for Action to Safely Deliver Oral Health Care during and Post COVID-19 Pandemic
Farronato, M., Tadakamadla, S. K., Quadri, M. F. A., Acharya, S., Tadakamadla, J., Love, R. M., Jamal, M., Mulder, R., Maspero, C. M. N., Farronato, D., et al. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17186704 · Cited by 55
Pathogenesis of taste impairment and salivary dysfunction in COVID-19 patients
Okada, Y., Yoshimura, K., Toya, S., & Tsuchimochi, M. (2021) · Japanese Dental Science Review · doi:10.1016/j.jdsr.2021.07.001 · Cited by 56
Khinda, J., Janjua, N. Z., Cheng, S. S. Y., van den Heuvel, E. R., Bhatti, P., & Darvishian, M. (2020) · Journal of Medical Virology · doi:10.1002/jmv.26411 · Cited by 53
A Model for SARS-CoV-2 Infection with Treatment
Chatterjee, A. N., & Basir, F. A. (2020) · Computational and Mathematical Methods in Medicine · doi:10.1155/2020/1352982 · Cited by 54
The role of androgens in COVID-19
Moradi, F., Enjezab, B., & Ghadiri‐Anari, A. (2020) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2020.10.014 · Cited by 54
Gutiérrez‐Bautista, J. F., Rodríguez-Nicolás, A., Rosales‐Castillo, A., Jiménez, P., Garrido, F., Anderson, P. O., Ruiz‐Cabello, F., & López‐Ruz, M. Á. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.596553 · Cited by 56
Neta, F. I., Fernandes, A. C. L., Vale, A. J. M., Pinheiro, F. I., Cobucci, R. N., de Azevedo, E. P., & Gúzen, F. P. (2021) · Current Research in Pharmacology and Drug Discovery · doi:10.1016/j.crphar.2021.100035 · Cited by 55
Zdanowski, W., & Waśniewski, T. (2021) · Vaccines · doi:10.3390/vaccines9060675 · Cited by 55
A mini-review on the impact of COVID 19 on vital organs
Shah, M. D., Sumeh, A. S., Sheraz, M. A., Kavitha, M. S., Maran, B. A. V., & Rodrigues, K. F. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112158 · Cited by 54
Sophorolipid: a glycolipid biosurfactant as a potential therapeutic agent against COVID-19
Daverey, A., Dutta, K., Joshi, S. J., & Daverey, A. (2021) · Bioengineered · doi:10.1080/21655979.2021.1997261 · Cited by 54
Galicia, J. C., Guzzi, P. H., Giorgi, F. M., & khan, A. W. A. (2020) · Genes and Immunity · doi:10.1038/s41435-020-00112-6 · Cited by 54
Jamshidi, E., Babajani, A., Soltani, P., & Niknejad, H. (2021) · Stem Cell Reviews and Reports · doi:10.1007/s12015-020-10109-3 · Cited by 54
Cantarella, G., Aldè, M., Consonni, D., Zuccotti, G., Berardino, F. D., Barozzi, S., Bertoli, S., Battezzati, A., Zanetti, D., & Pignataro, L. (2021) · Journal of Voice · doi:10.1016/j.jvoice.2021.03.009 · Cited by 54
Beware: Gastrointestinal symptoms can be a manifestation of COVID-19
Schmulson, M. J., Dávalos, M. F., & Berumen-Campos, J. (2020) · Revista de Gastroenterología de México (English Edition) · doi:10.1016/j.rgmxen.2020.04.001 · Cited by 56
COVID-19 as a viral functional ACE2 deficiency disorder with ACE2 related multi-organ disease
Gan, R., Rosoman, N., Henshaw, D. J. E., Noble, E. P., Georgius, P., & Sommerfeld, N. (2020) · Medical Hypotheses · doi:10.1016/j.mehy.2020.110024 · Cited by 53
Coronavirus Disease of 2019: a Mimicker of Dengue Infection?
Henrina, J., Putra, I. C. S., Lawrensia, S., Handoyono, Q. F., & Cahyadi, A. (2020) · SN Comprehensive Clinical Medicine · doi:10.1007/s42399-020-00364-3 · Cited by 53
Salivary Glands, Saliva and Oral Findings in COVID-19 Infection
Pedrosa, M. D. S., Sipert, C. R., & Nogueira, F. N. (2020) · Pesquisa Brasileira em Odontopediatria e Clínica Integrada · doi:10.1590/pboci.2020.112 · Cited by 62
Sohn, Y., Jeong, S. J., Chung, W. S., Hyun, J. H., Baek, Y. J., Cho, Y., Kim, J. H., Ahn, J. Y., Choi, J. Y., & Yeom, J. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9092924 · Cited by 53
Pathogenesis‐directed therapy of 2019 novel coronavirus disease
Stratton, C. W., Tang, Y., & Lu, H. (2020) · Journal of Medical Virology · doi:10.1002/jmv.26610 · Cited by 59
Yamazaki, W., Matsumura, Y., Thongchankaew-Seo, U., Yamazaki, Y., & Nagao, M. (2021) · Journal of Clinical Virology · doi:10.1016/j.jcv.2021.104760 · Cited by 53
Oral Mucosa, Saliva, and COVID-19 Infection in Oral Health Care
Atukorallaya, D., & Ratnayake, R. K. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.656926 · Cited by 53
Rodrigues, R., & Costa‐de‐Oliveira, S. (2021) · Microorganisms · doi:10.3390/microorganisms9081692 · Cited by 56
Zeng, W., Qi, K., Ye, M., Zheng, L., Liu, X., Hu, S., Zhang, W., Tang, W., Xu, J., Yu, D., et al. (2022) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000002072 · Cited by 52
Targeting Macrophages as a Therapeutic Option in Coronavirus Disease 2019
Gracia-Hernandez, M., Sotomayor, E. M., & Villagra, A. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.577571 · Cited by 54
Khiabani, K. S., & Amirzade-Iranaq, M. H. (2021) · American Journal of Infection Control · doi:10.1016/j.ajic.2021.03.008 · Cited by 53
Defining biological and biophysical properties of SARS-CoV-2 genetic material in wastewater
Robinson, C. A., Hsieh, H., Hsu, S.-Y., Wang, Y., Salcedo, B., Belenchia, A. M., Klutts, J., Zemmer, S. A., Reynolds, M., Semkiw, E., et al. (2021) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2021.150786 · Cited by 54
Ember, K. J. I., Daoust, F., Mahfoud, M., Dallaire, F., Zamani, E., Tran, T., Plante, A., Diop, M.-K., Nguyen, T., St-Georges-Robillard, A., et al. (2022) · Journal of Biomedical Optics · doi:10.1117/1.jbo.27.2.025002 · Cited by 54
Salivary diagnostics in COVID-19: Future research implications
Divya, V., & Balasubramanian, S. K. (2020) · Journal of Dental Sciences · doi:10.1016/j.jds.2020.04.006 · Cited by 51
NLR: A Cost-effective Nomogram to Guide Therapeutic Interventions in COVID-19
Kerboua, K. E. (2020) · Immunological Investigations · doi:10.1080/08820139.2020.1773850 · Cited by 50
COVID-19: Molecular and Cellular Response
Alipoor, S. D., Mortaz, E., Jamaati, H., Tabarsi, P., Bayram, H., Varahram, M., & Adcock, I. M. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.563085 · Cited by 53
Stevens-Johnson syndrome post second dose of Pfizer COVID-19 vaccine: a case report
Elboraey, M. O., & Essa, E. E. S. F. (2021) · Oral Surgery Oral Medicine Oral Pathology and Oral Radiology · doi:10.1016/j.oooo.2021.06.019 · Cited by 51
Rosa, L., Tripepi, G. L., Naldi, E., Aimati, M., Santangeli, S., Venditto, F., Caldarelli, M., & Valenti, P. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10184276 · Cited by 51
Implications of testicular ACE2 and the renin–angiotensin system for SARS-CoV-2 on testis function
Edenfield, R. C., & Easley, C. A. (2021) · Nature Reviews Urology · doi:10.1038/s41585-021-00542-5 · Cited by 55
Design Strategies for and Stability of mRNA–Lipid Nanoparticle COVID-19 Vaccines
Liu, T., Tian, Y., Zheng, A., & Cui, C. (2022) · Polymers · doi:10.3390/polym14194195 · Cited by 54
Verstockt, B., Verstockt, S., Abdurahiman, S., Ke, B.-J., Arnauts, K., Cleynen, I., Sabino, J., Ferrante, M., Matteoli, G., & Vermeire, S. (2020) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjaa185 · Cited by 49
Effect of Biomedical Materials in the Implementation of a Long and Healthy Life Policy
Dobrzański, L. A., Dobrzańska-Danikiewicz, A. D., & Dobrzański, L. B. (2021) · Processes · doi:10.3390/pr9050865 · Cited by 53
Cardone, M., Yano, M., Rosenberg, A. S., & Puig, M. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01131 · Cited by 49
The Impact of COVID-19 on Cancer Risk and Treatment
Jyotsana, N., & King, M. R. (2020) · Cellular and Molecular Bioengineering · doi:10.1007/s12195-020-00630-3 · Cited by 50
An updated min-review on environmental route of the SARS-CoV-2 transmission
Hoseinzadeh, E., Javan, S., Farzadkia, M., Mohammadi, F., Hossini, H., & Taghavi, M. (2020) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2020.111015 · Cited by 50
Coronavirus (SARS-CoV-2) Pandemic: Future Challenges for Dental Practitioners
Bordea, I. R., Xhajanka, E., Candrea, S., Bran, S., Onisor, F. G., Inchingolo, A. D., Malcangi, G., Pham, V. H., Inchingolo, A. M., Scarano, A., et al. (2020) · Microorganisms · doi:10.3390/microorganisms8111704 · Cited by 50
García‐Azorín, D., Abildúa, M. J. A., Aguirre, M. E. E., Fernández, S. F., Moncó, J. C. G., Guijarro-Castro, C., González-Platas, M., Delgado, F. R., Andrés, J. M. L., Ezpeleta, D., et al. (2020) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2020.117283 · Cited by 56
A Comparative Systematic Review of COVID-19 and Influenza
Osman, M., Klopfenstein, T., Belfeki, N., Gendrin, V., & Zayet, S. (2021) · Viruses · doi:10.3390/v13030452 · Cited by 50
Nexus between COVID-19 and periodontal disease
Sukumar, K., & Tadepalli, A. (2021) · Journal of International Medical Research · doi:10.1177/03000605211002695 · Cited by 55
Management of post-COVID-19 olfactory dysfunction
Wu, T. J., Yu, A. C., & Lee, J. T. (2022) · Current Treatment Options in Allergy · doi:10.1007/s40521-021-00297-9 · Cited by 50
Periodontitis and coronavirus disease 2019
Tamimi, F., Altigani, S., & Sanz, M. (2022) · Periodontology 2000 · doi:10.1111/prd.12434 · Cited by 50
Gastrointestinal Involvement in SARS-CoV-2 Infection
Chen, T., Hsu, M., Lee, M., & Chou, C. (2022) · Viruses · doi:10.3390/v14061188 · Cited by 56
Martins‐Chaves, R. R., Gomes, C. C., & Gomez, R. S. (2020) · Brazilian Oral Research · doi:10.1590/1807-3107bor-2020.vol34.0048 · Cited by 49
Taste and Smell Dysfunction in COVID-19 Patients
Abalo-Lojo, J. M., Pouso-Diz, J. M., & González, F. (2020) · Annals of Otology Rhinology & Laryngology · doi:10.1177/0003489420932617 · Cited by 49
Sato, T., Ueha, R., Goto, T., Yamauchi, A., Kondo, K., & Yamasoba, T. (2020) · The Laryngoscope · doi:10.1002/lary.29132 · Cited by 49
Chlorhexidine: An effective anticovid mouth rinse
Jain, A. R., Grover, V., Singh, C., Sharma, A., Das, D. K., Singh, P. R., Thakur, K. G., & Ringe, R. P. (2021) · Journal of Indian Society of Periodontology · doi:10.4103/jisp.jisp_824_20 · Cited by 49
Awasthi, S., Wagner, T., Venkatakrishnan, A., Puranik, A., Hurchik, M., Agarwal, V., Conrad, I., Kirkup, C., Arunachalam, R., O’Horo, J. C., et al. (2021) · Cell Death Discovery · doi:10.1038/s41420-021-00429-9 · Cited by 49
Valdez‐Cruz, N. A., García‐Hernández, E., Espitia, C., Cobos-Marín, L., Altamirano, C., Bando-Campos, C. G., Cofas‐Vargas, L. F., Coronado-Aceves, E. W., González-Hernández, R. A., Hernández‐Peralta, P., et al. (2021) · Microbial Cell Factories · doi:10.1186/s12934-021-01576-5 · Cited by 52
Dental biofilm of symptomatic COVID‐19 patients harbours SARS‐CoV‐2
Gomes, S. C., Fachin, S., da Fonseca, J. G., Angst, P. D. M., Lamers, M. L., Brum, I. S., & Nunes, L. N. (2021) · Journal Of Clinical Periodontology · doi:10.1111/jcpe.13471 · Cited by 49
Huyut, M. T., & İlkbahar, F. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.107838 · Cited by 50
Oral health conditions and COVID-19: A systematic review and meta-analysis of the current evidence
Qi, X., Northridge, M. E., Hu, M., & Wu, B. (2022) · Aging and Health Research · doi:10.1016/j.ahr.2022.100064 · Cited by 49
SARS‐CoV‐2: What can saliva tell us?
Braz‐Silva, P. H., Pallos, D., Giannecchini, S., & To, K. K. (2020) · Oral Diseases · doi:10.1111/odi.13365 · Cited by 52
Oral mucosa lesions in COVID‐19
Petrescu, N. B., LUCACIU, O. P., & Roman, A. (2020) · Oral Diseases · doi:10.1111/odi.13499 · Cited by 49
SARS-CoV-2 Infection and the Newborn
Ovalı, F. (2020) · Frontiers in Pediatrics · doi:10.3389/fped.2020.00294 · Cited by 64
Tan, H. W., Xu, Y., & Lau, A. T. Y. (2020) · Reviews in Medical Virology · doi:10.1002/rmv.2122 · Cited by 47
SARS-CoV-2 Infection and Oral Health: Therapeutic Opportunities and Challenges
Coke, C. J., Davison, B., Fields, N., Fletcher, J., Rollings, J., Roberson, L., Challagundla, K. B., Sampath, C., Cade, J., Farmer‐Dixon, C. M., et al. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10010156 · Cited by 50
Active matrix metalloproteinase-8 (aMMP-8) point-of-care test (POCT) in the COVID-19 pandemic
Sorsa, T. A., Sahni, V., Buduneli, N., Gupta, S., Räisänen, I. T., Golub, L. M., Lee, H., Pätilä, T., Bostancı, N., Meurman, J. H., et al. (2021) · Expert Review of Proteomics · doi:10.1080/14789450.2021.1976151 · Cited by 48
Aleksova, A., Ferro, F., Gagno, G., Cappelletto, C., Santon, D., Rossi, M., Ippolito, G., Zumla, A. I., Beltrami, A. P., & Sinagra, G. (2020) · Journal of Internal Medicine · doi:10.1111/joim.13101 · Cited by 48
Vaccines and Therapies in Development for SARS-CoV-2 Infections
Wu, D. B.-C., Koganti, R., Lambe, U. P., Yadavalli, T., Nandi, S. S., & Shukla, D. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9061885 · Cited by 47
Pharmacotherapy in COVID-19 patients: a review of ACE2-raising drugs and their clinical safety
Akhtar, S., Benter, I. F., Danjuma, M. I.-M., Doi, S. A. R., Hasan, S. S., & Habib, A. M. (2020) · Journal of drug targeting · doi:10.1080/1061186x.2020.1797754 · Cited by 49
The relationship between COVID-19 and the dental damage stage determined by radiological examination
Şirin, D. A., & Özçelik, F. (2021) · Oral Radiology · doi:10.1007/s11282-020-00497-0 · Cited by 48
The role of vitamin D in reducing SARS-CoV-2 infection: An update
Alam, M. S., Czajkowsky, D. M., Islam, M. A., & Rahman, M. A. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.107686 · Cited by 49
Eight-month follow-up of olfactory and gustatory dysfunctions in recovered COVID-19 patients
Biadsee, A., Dagan, O., Ormianer, Z., Kassem, F., Masarwa, S., & Biadsee, A. (2021) · American Journal of Otolaryngology · doi:10.1016/j.amjoto.2021.103065 · Cited by 49
Patrì, A., Gallo, L., Guarino, M., & Fabbrocini, G. (2020) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2020.03.098 · Cited by 47
Nouchi, A., Chastang, J., Miyara, M., Lejeune, J., Soares, A., Ibañez, G. E., Saadoun, D., Morélot‐Panzini, C., Similowski, T., Amoura, Z., et al. (2020) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-020-04056-7 · Cited by 46
SARS-CoV-2 Disease Adjuvant Therapies and Supplements Breakthrough for the Infection Prevention
Inchingolo, A. D., Inchingolo, A. M., Bordea, I. R., Malcangi, G., Xhajanka, E., Scarano, A., Lorusso, F., Farronato, M., Tartaglia, G. M., Isacco, C. G., et al. (2021) · Microorganisms · doi:10.3390/microorganisms9030525 · Cited by 49
Wang, Y., Deng, H., Pan, Y., Jin, L., Hu, R., Lu, Y., Deng, W., Sun, W., Chen, C., Shen, X., et al. (2021) · Journal of Translational Medicine · doi:10.1186/s12967-021-03198-2 · Cited by 49
Hematological manifestations of COVID-19
Mina, A. A., van Besien, K., & Platanias, L. C. (2020) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428194.2020.1788017 · Cited by 47
Roadmap to the Bioanalytical Testing of COVID-19: From Sample Collection to Disease Surveillance
Hosseini, A., Pandey, R., Osman, E., Victorious, A. P., Li, F., Didar, T. F., & Soleymani, L. (2020) · ACS Sensors · doi:10.1021/acssensors.0c01377 · Cited by 50
Zhao, Y., Yu, C., Ni, W., Shen, H., Qiu, M., & Zhao, Y. (2020) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.23657 · Cited by 46
Neurosensory dysfunction: A diagnostic marker of early COVID-19
Liang, Y., Xu, J., Chu, M., Mai, J., Lai, N., Tang, W., TuanJie, Y., Zhang, S., Guan, C., Zhong, F., et al. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.06.086 · Cited by 46
Azizi, S. A., & Azizi, S. (2020) · Journal of NeuroVirology · doi:10.1007/s13365-020-00903-7 · Cited by 48
Repurposing existing drugs for COVID-19: an endocrinology perspective
Cadegiani, F. (2020) · BMC Endocrine Disorders · doi:10.1186/s12902-020-00626-0 · Cited by 46
Angiotensin-converting enzyme 2 and COVID-19: patients, comorbidities, and therapies
Pathangey, G., Fadadu, P., Hospodar, A. R., & Abbas, A. E. (2020) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00259.2020 · Cited by 48
A bibliometric analysis of the dental scientific literature on COVID-19
Jaćimović, J., Jakovljević, A., Nagendrababu, V., Duncan, H. F., & Dummer, P. M. H. (2021) · Clinical Oral Investigations · doi:10.1007/s00784-021-03916-6 · Cited by 46
Quantifying Renin-Angiotensin-System Alterations in COVID-19
Pucci, F., Annoni, F., Santos, R. A. S., Taccone, F. S., & Rooman, M. J. (2021) · Cells · doi:10.3390/cells10102755 · Cited by 53
Metadata
- Authors
- Xu, H., Zhong, L., Deng, J., Peng, J., Dan, H., Zeng, X., Li, T., & Chen, Q.
- Affiliations
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Corresponding author
- Li, Taiwen
- Venue
- International Journal of Oral Science
- Published
- 2020-02-24
- Volume
- 12
- Issue
- 1
- Pages
- 8-8
- ISSN
- 1674-2818 (ISSN-L)
- 2049-3169
- PMC
- PMC7039956
- OpenAlex
- W3008295344
- Cited by
- 2,838
- References
- 26
- Citations by year
- 2026: 32 · 2025: 59 · 2024: 136 · 2023: 287 · 2022: 469 · 2021: 846 · 2020: 1003
- FWCI
- 85.00
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- International Journal of Oral Science (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Informationszentrum Lebenswissenschaften (ZB MED) (submittedVersion, cc-by)
- PUBLISSO (German National Library of Medicine) (submittedVersion, cc-by)
- Funders
- National Natural Science Foundation of China (111 Project, 81991502, B14038, 81771081, 81520108009, 81991500)
- Ministry of Education, India
- Higher Education Discipline Innovation Project (B14038)
- Topics
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Health Sciences › Dentistry › General Dentistry › Dental Research and COVID-19
- Health Sciences › Medicine › Dermatology › Dermatological and COVID-19 studies
- Keywords
- ACE2 receptor, SARS-CoV-2, oral mucosa, host cell receptors, viral entry, infection susceptibility, single-cell transcriptomics, gene expression profiling, dental disease prevention
- MeSH terms
- Betacoronavirus, Angiotensin-Converting Enzyme 2, COVID-19, SARS-CoV-2, Epithelial Cells, Humans, Peptidyl-Dipeptidase A, Mouth Mucosa, Pneumonia, Viral, Tongue, Coronavirus Infections, Gene Expression Profiling, Databases, Genetic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-09-28, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-09-28 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
